BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 30573850)

  • 1. ALK-positive histiocytosis: an expanded clinicopathologic spectrum and frequent presence of KIF5B-ALK fusion.
    Chang KTE; Tay AZE; Kuick CH; Chen H; Algar E; Taubenheim N; Campbell J; Mechinaud F; Campbell M; Super L; Chantranuwat C; Yuen ST; Chan JKC; Chow CW
    Mod Pathol; 2019 May; 32(5):598-608. PubMed ID: 30573850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local ALK-Positive Histiocytosis With Unusual Morphology and Novel
    Tran TAN; Chang KTE; Kuick CH; Goh JY; Chang CC
    Int J Surg Pathol; 2021 Aug; 29(5):543-549. PubMed ID: 33243034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case report: Systemic presentation of ALK-positive Histiocytosis.
    Wei Y; Zhang R; Lin D; Chen X; Li L; Huang H
    Front Oncol; 2024; 14():1366766. PubMed ID: 38706599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case report: ALK-positive histiocytosis presented as bilateral synchronous breast masses with long-term remission on crizotinib.
    Zhou Y; Hurtado-Castillo M; Pandey O
    Front Med (Lausanne); 2023; 10():1288849. PubMed ID: 38093982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Letter to the Editor Regarding "Local ALK-Positive Histiocytosis with Unusual Morphology and Novel
    Soylemez Akkurt T; Dur Karasayar AH; Gurbuz BC; Altınay S; Yuzkan S; Baskan F
    Int J Surg Pathol; 2023 Oct; 31(7):1426-1429. PubMed ID: 36471533
    [No Abstract]   [Full Text] [Related]  

  • 6. Localised ALK-positive histiocytosis in lung with EML4::ALK fusion.
    Zou L; Lu T; Li M; Wang A; Zhang Z; Pan B; Sun J
    Pathology; 2024 Jun; 56(4):604-606. PubMed ID: 38097451
    [No Abstract]   [Full Text] [Related]  

  • 7. [ALK positive histiocytosis with multiple system involvement: report of a case].
    Yao S; Zhang F; Chen Y; Liu YH
    Zhonghua Bing Li Xue Za Zhi; 2024 May; 53(5):495-497. PubMed ID: 38678335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaplastic lymphoma kinase-positive histiocytosis with multisystem involvement: A case report.
    Tu Y; Lu Y
    Pediatr Dermatol; 2024; 41(3):551-553. PubMed ID: 38346136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kemps PG, Picarsic J, Durham BH, et al. ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition. Blood. 2022;139(2):256-280.
    Blood; 2023 Jun; 141(22):2785-2786. PubMed ID: 37261851
    [No Abstract]   [Full Text] [Related]  

  • 10. Pathologic characteristics of histiocytic and dendritic cell neoplasms.
    Yoon SO
    Blood Res; 2024 May; 59(1):18. PubMed ID: 38713245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult Onset Orbital Xanthogranuloma, a Variant of Adult Orbital Xanthogranulomatous Disease: An Infrequent Entity.
    Lakavarapukota S; Gopal KVT; Karri SB; Bulla RR
    Indian Dermatol Online J; 2024; 15(2):266-269. PubMed ID: 38550817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rare differential diagnosis of an osteolytic lesion of the mandible in a young adult].
    Shin H; Naros A; Kieninger S; Polligkeit J; Fend F; Milla J
    Pathologie (Heidelb); 2024 Apr; ():. PubMed ID: 38602523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A male infant with ALK-positive histiocytosis recovered spontaneously.
    Xu Z; Huang L; Xue R
    Clin Exp Dermatol; 2024 May; 49(6):620-622. PubMed ID: 38240038
    [No Abstract]   [Full Text] [Related]  

  • 14. ALK-Positive Histiocytosis-A Distinct Histiocytic Entity Deserving Recognition-Reply.
    Xu J; Yao X; Xu Z
    JAMA Dermatol; 2024 Apr; ():. PubMed ID: 38656502
    [No Abstract]   [Full Text] [Related]  

  • 15. ALK-Positive Histiocytosis-A Distinct Histiocytic Entity Deserving Recognition.
    Kemps PG; Picarsic JL; Emile JF
    JAMA Dermatol; 2024 Apr; ():. PubMed ID: 38656284
    [No Abstract]   [Full Text] [Related]  

  • 16. CSF1R inhibition for histiocytic neoplasm with CBL mutations refractory to MEK1/2 inhibition.
    Diamond EL; Francis JH; Lacouture ME; Rotemberg V; Yabe M; Petrova-Drus K; Ulaner GA; Reddy R; Abdel-Wahab O; Durham BH
    Leukemia; 2023 Aug; 37(8):1737-1740. PubMed ID: 37355734
    [No Abstract]   [Full Text] [Related]  

  • 17. ALK-positive histiocytosis with KIF5B-ALK fusion in the central nervous system.
    Lucas CG; Gilani A; Solomon DA; Liang X; Maher OM; Chamyan G; Kleinschmidt-Demasters BK; Perry A
    Acta Neuropathol; 2019 Aug; 138(2):335-337. PubMed ID: 31119374
    [No Abstract]   [Full Text] [Related]  

  • 18. ALK-positive Histiocytosis of the Breast: A Clinicopathologic Study Highlighting Spindle Cell Histology.
    Kashima J; Yoshida M; Jimbo K; Izutsu K; Ushiku T; Yonemori K; Yoshida A
    Am J Surg Pathol; 2021 Mar; 45(3):347-355. PubMed ID: 32826530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ALK-positive histiocytosis with
    Gupta GK; Xi L; Pack SD; Jones JB; Pittaluga S; Raffeld M; Jaffe ES
    Haematologica; 2019 Nov; 104(11):e534-e536. PubMed ID: 31371408
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical, pathological, and genomic features of EWSR1-PATZ1 fusion sarcoma.
    Bridge JA; Sumegi J; Druta M; Bui MM; Henderson-Jackson E; Linos K; Baker M; Walko CM; Millis S; Brohl AS
    Mod Pathol; 2019 Nov; 32(11):1593-1604. PubMed ID: 31189996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.